You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Lutathera

Showing 1 - 25 of 43
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Bronchial and Thymic Neuroendocrine Tumour, Paraganglioma/ Phaeochromocytoma, Medullary Thyroid Carcinoma Trial (Lu-177 DOTATATE

Not yet recruiting
  • Bronchial and Thymic Neuroendocrine Tumour
  • +3 more
  • Lu-177 DOTATATE (Lutathera®)
  • (no location specified)
Nov 1, 2023

Patients Re-treated With Lutetium-177 DOTATATE (Lutathera®)

Completed
  • Neuroendocrine Tumor
  • Lutetium-177 DOTATATE
  • Houston, Texas
    Excel Diagnostics & Nuclear Oncology Center
Apr 16, 2023

LUTATHERA Injection General Use Result Survey

Recruiting
  • Somatostatin Receptor-positive Neuroendocrine Tumor
  • LUTATHERA
  • Kashiwa, Chiba, Japan
  • +6 more
Apr 25, 2023

Neuroendocrine Tumors Trial in Lexington (Telotristat (Low-Dose), Telotristat (High-Dose))

Recruiting
  • Neuroendocrine Tumors
  • Telotristat (Low-Dose)
  • Telotristat (High-Dose)
  • Lexington, Kentucky
    Markey Cancer Center
Nov 10, 2022

Pheochromocytoma, Paraganglioma, Neuroendocrine Tumors Trial run by the NCI (Lu-177-DOTATATE, Ga-68-DOTATATE, F-18-FDG)

Recruiting
  • Pheochromocytoma
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 19, 2023

Neuroendocrine Tumors Trial (Lutathera)

Not yet recruiting
  • Neuroendocrine Tumors
  • Lutathera
  • (no location specified)
Aug 9, 2023

Gastroenteropancreatico Tumors, Neuroendocrine Tumors, Neuroendocrine Tumors Trial run by the National Cancer Institute (NCI)

Recruiting
  • Gastroenteropancreatico Tumors
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 19, 2023

Gastro-enteropancreatic Neuroendocrine Tumor, Neuroendocrine Tumors Trial in Iowa City (Lutathera, Azedra)

Not yet recruiting
  • Gastro-enteropancreatic Neuroendocrine Tumor
  • Neuroendocrine Tumors
  • Iowa City, Iowa
    Holden Comprehensive Cancer Center
Jul 7, 2022

Lutathera® in Somatostatin Receptor Positive

Recruiting
  • Somatostatin Receptor-positive GEP-NET
  • Lutathera
  • Seongnam Si, Gyeonggi Do, Korea, Republic of
  • +4 more
Jun 29, 2022

Grade 1 Meningioma, Grade 2 Meningioma, Grade 3 Meningioma Trial in Rochester (radiation, drug, procedure, other)

Recruiting
  • Grade 1 Meningioma
  • +4 more
  • Gallium Ga 68-DOTATATE
  • +5 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 11, 2023

High Grade Glioma, Meningioma, Embryonal Tumor Trial in United States (LUTATHERA® (Lutetium Lu 177 dotatate))

Recruiting
  • High Grade Glioma
  • +12 more
  • LUTATHERA® (Lutetium Lu 177 dotatate)
  • Aurora, Colorado
  • +8 more
Jan 16, 2023

Neuroendocrine Tumors, Somatostatin Receptor-positive Neuroendocrine Tumor Trial in Madison (Single Photon Emission Computed

Not yet recruiting
  • Neuroendocrine Tumors
  • Somatostatin Receptor-positive Neuroendocrine Tumor
  • Single Photon Emission Computed Tomography/ Computed Tomography (SPECT/CT)
  • +3 more
  • Madison, Wisconsin
    University of Wisconsin - Madison
Nov 2, 2023

Metastatic Pancreatic Neuroendocrine Tumor, Pancreatic Tumor, Stage III Pancreatic Neuroendocrine Tumor AJCC v8 Trial

Not yet recruiting
  • Metastatic Pancreatic Neuroendocrine Tumor
  • +4 more
  • Biospecimen Collection
  • +5 more
  • (no location specified)
Jan 14, 2023

Effectiveness and Outcomes Associated With Lutathera Treatment

Active, not recruiting
  • Gastroenteropancreatic Neuroendocrine Tumor
  • Alessandria, Italy
  • +17 more
May 4, 2022

Neuroendocrine Tumors, Intestinal Well Differentiated Endocrine Tumor, Progressive Disease Trial in France (Lutathera)

Recruiting
  • Neuroendocrine Tumors
  • +2 more
  • Lutathera
  • Angers, France
  • +21 more
Aug 2, 2022

Neuroendocrine Tumors Trial (Lutathera)

Not yet recruiting
  • Neuroendocrine Tumors
  • Lutathera
  • (no location specified)
Aug 23, 2022

Neuroendocrine Tumors, Liver-Dominant Metastatic Pancreatic Neuroendocrine Tumors Trial in New York (177Lu-DOTATATE)

Recruiting
  • Neuroendocrine Tumors
  • Liver-Dominant Metastatic Pancreatic Neuroendocrine Tumors
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 19, 2023

Gastroenteropancreatic Neuroendocrine Tumors, Pheochromocytoma, Paraganglioma Trial in Worldwide (Lutetium [177Lu]

Recruiting
  • Gastroenteropancreatic Neuroendocrine Tumors
  • +2 more
  • Lutetium [177Lu] oxodotreotide/dotatate
  • Iowa City, Iowa
  • +16 more
Apr 6, 2022

Dosimetry Trial in Vandoeuvre/les/nancy (Single Photon Emission Computed Tomography/ Computed Tomography (SPECT/CT))

Recruiting
  • Dosimetry
  • Single Photon Emission Computed Tomography/ Computed Tomography (SPECT/CT)
  • Vandoeuvre/les/nancy, France
    Chru Nancy
Aug 3, 2021

Pancreatic Neuroendocrine Tumor, Pancreas Cancer Trial in Chicago (cytoreductive surgery, Lutathera - a small molecule used in

Not yet recruiting
  • Pancreatic Neuroendocrine Tumor
  • Pancreas Cancer
  • cytoreductive surgery
  • +2 more
  • Chicago, Illinois
    The University of Chicago
Nov 8, 2022

Merkel Cell Carcinoma Trial (Pembrolizumab, Lutetium Lu 177 dotatate)

Not yet recruiting
  • Merkel Cell Carcinoma
  • (no location specified)
Oct 12, 2022

Metastatic Malignant Tumor in the Viscera, Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation, Metastatic

Not yet recruiting
  • Metastatic Malignant Neoplasm in the Viscera
  • +4 more
  • Lutetium Lu 177 Dotatate
  • (no location specified)
Jan 25, 2023

Gastroenteropancreatic Neuroendocrine Tumor Trial in Stanford (Lutathera, Gallium 68 Dotatate, Computed Tomography (CT))

Suspended
  • Gastroenteropancreatic Neuroendocrine Tumor
  • Lutathera
  • +4 more
  • Stanford, California
    Stanford Cancer Institute Palo Alto
Sep 21, 2022

Metastatic Malignant Tumor in the Liver, Neuroendocrine Tumor Trial in San Francisco (procedure, biological, device)

Recruiting
  • Metastatic Malignant Neoplasm in the Liver
  • Neuroendocrine Neoplasm
  • Arterial Embolization
  • +3 more
  • San Francisco, California
    University of California, San Francisco
Dec 22, 2022

Neuroendocrine Tumors Trial in Portland (Cabozantinib, Lu-177)

Not yet recruiting
  • Neuroendocrine Tumors
  • Portland, Oregon
    Providence Portland Cancer Institute - Franz Clinic
Feb 10, 2022